Skip to main content
    E

    Elevance Health Inc (ELV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $431.47
    -8.48 (-1.93%)

    Market Cap: $95.41B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(36/40)
    Avg Surprise
    +5.98%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$7.07
    Range$5.38 - $7.70
    22 analysts
    Revenue Consensus
    $52.8B
    Range$51.0B - $54.3B
    11 analysts
    Period ending Mar 31, 2027
    EPS Consensus$12.26
    Range$8.69 - $13.23
    13 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$12.03+1.9%
    60d ago$12.03+1.9%
    30d ago$12.12+1.2%
    7d ago$12.14+1.0%
    Current$12.26
    Revenue Consensus
    $50.1B
    Range$49.3B - $51.1B
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$12.26---
    Dec 26EST
    		-$7.07---
    Sep 26
    Reported Oct 21
    		$6.99$4.66+50.00%Beat+15.9%
    Jun 26
    Reported Jul 15
    		$7.45$6.18+20.55%Beat-15.7%
    Mar 26
    Reported Apr 22
    		$12.58$10.81+16.37%Beat+5.1%
    Dec 25
    Reported Jan 28
    		$3.33$3.09+7.77%Beat-13.3%
    Sep 25
    Reported Oct 21
    		$6.03$4.94+22.06%Beat-28.0%
    Jun 25
    Reported Jul 17
    		$8.84$8.92-0.90%Miss-12.6%
    Mar 25
    Reported Apr 22
    		$11.97$11.48+4.27%Beat+12.5%
    Dec 24
    Reported Jan 23
    		$3.84$3.85-0.26%Miss-31.7%
    Sep 24
    Reported Oct 17
    		$8.37$9.65-13.26%Miss-6.9%
    Jun 24
    Reported Jul 17
    		$10.12$10.01+1.10%Beat+11.9%
    Mar 24
    Reported Apr 18
    		$10.64$10.53+1.04%Beat+12.5%
    Dec 23
    Reported Jan 24
    		$5.62$5.59+0.54%Beat+7.5%
    Sep 23
    Reported Oct 18
    		$8.99$8.46+6.26%Beat+19.4%
    Jun 23
    Reported Jul 19
    		$9.04$8.78+2.96%Beat+12.4%
    Mar 23
    Reported Apr 19
    		$9.46$9.28+1.94%Beat+14.7%
    Dec 22
    Reported Jan 25
    		$5.23$5.19+0.77%Beat+1.8%
    Sep 22
    Reported Oct 19
    		$7.53$7.15+5.31%Beat+10.9%
    Jun 22
    Reported Jul 20
    		$8.04$7.74+3.88%Beat+14.4%
    Mar 22
    Reported Apr 20
    		$8.25$7.83+5.36%Beat+17.7%
    Dec 21
    Reported Jan 26
    		$5.14$5.12+0.39%Beat+102.4%
    Sep 21
    Reported Oct 20
    		$6.79$6.37+6.59%Beat+61.7%
    Jun 21
    Reported Jul 21
    		$7.03$6.34+10.88%Beat-23.6%
    Mar 21
    Reported Apr 21
    		$7.01$6.47+8.35%Beat+8.2%
    Dec 20
    Reported Jan 27
    		$2.54$2.53+0.40%Beat-34.5%
    Sep 20
    Reported Oct 28
    		$4.20$4.18+0.48%Beat-13.8%
    Jun 20
    Reported Jul 29
    		$9.20$8.58+7.23%Beat+98.3%
    Mar 20
    Reported Apr 29
    		$6.48$6.44+0.62%Beat+7.5%
    Dec 19
    Reported Jan 29
    		$3.88$3.89-0.26%Miss+59.0%
    Sep 19
    Reported Oct 23
    		$4.87$4.82+1.04%Beat+27.8%
    Jun 19
    Reported Jul 24
    		$4.64$4.62+0.43%Beat+9.2%
    Mar 19
    Reported Apr 24
    		$6.03$5.90+2.20%Beat+11.5%
    Dec 18
    Reported Jan 30
    		$2.44$2.20+10.91%Beat+89.1%
    Sep 18
    Reported Oct 31
    		$3.81$3.70+2.97%Beat+43.8%
    Jun 18
    Reported Jul 25
    		$4.25$4.18+1.67%Beat+26.1%
    Mar 18
    Reported Apr 25
    		$5.41$4.89+10.63%Beat+15.6%
    Dec 17
    Reported Jan 31
    		$1.29$1.27+1.57%Beat-26.7%
    Sep 17
    Reported Oct 25
    		$2.65$2.40+10.42%Beat-
    Jun 17
    Reported Jul 26
    		$3.37$3.24+4.01%Beat-
    Mar 17
    Reported Apr 26
    		$4.68$3.81+22.83%Beat-
    Dec 16
    Reported Feb 1
    		$1.76$1.76+0.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.59%
    Forward Annual Dividend$6.88
    Payout Ratio19.54%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+10.14%
    5Y CAGR+12.47%
    ELV dividend history and ex-dividend datesRun ELV in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio14.22EV/EBITDA12.37x
    Price/FCF14.31xFCF Yield6.99%
    Profitability
    Profit Margin2.55%Operating Margin4.22%
    ROE11.50%ROIC8.33%
    Financial Health
    Debt/Equity0.69xInterest Coverage5.33x
    Current Ratio1.47xQuick Ratio1.47x
    Trading Statistics
    Beta0.71Avg Volume1.33M
    52-Week High$450.6952-Week Low$270.87

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$433.13
    SMA 20$415.78
    SMA 50$408.11
    SMA 200$369.47
    EMA 10$431.02
    EMA 20$422.49
    EMA 50$410.55
    EMA 200$381.60

    MACD

    Line: 9.93Signal: 7.87Hist: 2.06

    ADX

    ADX: 27.1+DI: 24.2-DI: 14.4

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down32.0
    PSAR$450.69

    Bollinger Bands

    Upper Band$456.25
    Lower Band$375.30
    %B Position1947%(Upper)
    Band Width0.69

    RSI (14-Day)

    Neutral
    59.0

    Momentum Oscillators

    Stoch %K78.9
    Stoch %D83.7
    Williams %R-35.9
    ROC (10d)2.2%
    Momentum9.38
    CCI (20d)68.6
    MFI (14d)71.1

    Volatility Measures

    ATR (14d)$11.55(2.7%)
    StdDev (20d)20.24
    Hist Vol24.2%(Moderate)

    Volume Flow

    VWAP$434.52
    OBV8.6M
    AD Line-638.9M
    CMF (20d)0.019

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio1.0x
    VWMA (20d)$419.05

    Pivot Points

    R3$450.33
    R2$447.88
    R1$443.91
    Pivot Point$441.46
    S1$437.49
    S2$435.04
    S3$431.07

    Advanced Oscillators

    TSI28.20
    Ultimate Osc47.0
    KST70.39

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$51.43B$50.47B$50.18B$49.75B$50.71B$49.78B$48.89B$45.44B$45.15B$43.65B$42.58B$42.65B
    Cost of Revenue$43.42B$42.52B$41.08B$43.59B$43.52B$42.00B$40.30B$54.27B$43.31B$35.39B$34.37B$31.35B
    Gross Profit$8.01B$7.96B$9.10B$6.16B$7.19B$7.78B$8.60B$-8,826,000,000$1.83B$8.25B$8.21B$11.29B
    Operating Expenses$5.86B$5.66B$6.44B$5.58B$5.43B$5.14B$5.46B$-9,772,000,000$122.00M$5.23B$5.00B$10.03B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$5.75B$5.55B$6.33B$5.42B$5.27B$5.00B$5.30B$0$0$5.07B$4.89B$0
    Operating Income$2.15B$2.30B$2.66B$581.00M$1.76B$2.63B$3.14B$946.00M$1.71B$3.03B$3.20B$1.26B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$358.00M$364.00M$357.00M$366.00M$351.00M$341.00M$344.00M$340.00M$300.00M$280.00M$265.00M$259.00M
    Income Before Tax$1.79B$1.94B$2.30B$215.00M$1.41B$2.29B$2.80B$606.00M$1.37B$2.99B$2.94B$1.00B
    Income Tax Expense$451.00M$483.00M$544.00M$-331,000,000$219.00M$548.00M$613.00M$193.00M$365.00M$685.00M$690.00M$170.00M
    Net Income$1.34B$1.45B$1.76B$546.00M$1.19B$1.74B$2.18B$413.00M$1.01B$2.30B$2.25B$831.00M
    EBITDA$2.52B$2.67B$3.02B$987.00M$2.14B$3.01B$3.51B$1.34B$2.00B$3.60B$3.54B$1.68B
    EBIT$2.15B$2.30B$2.66B$581.00M$1.76B$2.63B$3.14B$946.00M$1.67B$3.27B$3.20B$1.26B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    I Tested One Of Wall Street’s Favorite AI Trades - It Failed

    Travelers Q2 core income $10.04 vs $5.41 consensus, stock +10%; CEO credited AI for a 0.5 percentage-point improvement in underlying loss ratio while expense ratio rose to 29%. Wall Street thesis posits AI cuts SG&A to create EPS torque in low-margin giants - e.g....

    Leo Nelissen
    •
    8/2/26
    •
    256
    AI Stocks
    Also mentions:
    TRVCVSKRWMTUNH

    Health Insurer Stocks: Recent Crash is Likely An Attractive Buffett Style "Fat Pitch" Opportunity

    Monday Jan 27th was "The Monday night massacre" when Medicare announced a 0.7% increase in reimbursement rates for 2026. 5% to 6% was the consensus and health insurance companies fell between 8% and 20% in overnight trading. Only Humana has continued to decline (-26% so far) but Morningstar (and I)...

    Adam Galas
    •
    1/29/26
    •
    332
    value investing, Income, Value, Dividend Growth, Dividend Investing
    Also mentions:
    ELVCVSHUM

    Government Contracts

    Gov Obligations (TTM)
    $209.42M
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    -29.8%
    Active Awards
    8
    New Awards (TTM)
    0
    Avg Remaining Term
    8.3 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    ELV Valuation and Fair Value

    P/E
    14.2x
    Forward P/E
    14.2x
    EV/EBITDA
    12.4x
    P/FCF
    14.3x
    PEG
    1.4x
    P/B
    2.1x
    See GNG's fair value

    ELV Profitability: Margins, ROIC and FCF

    Gross margin
    15.5%
    Operating margin
    4.2%
    Net margin
    2.5%
    ROIC
    8.3%
    ROE
    11.5%
    FCF margin
    3.2%
    FCF yield
    7.0%

    ELV Competitors

    CompanyTicker
    Sanofi ADRSNY
    Regeneron Pharmaceuticals IncREGN
    HCA Healthcare, Inc.HCA
    Cigna CorpCI
    GlaxoSmithKline PLC ADRGSK
    Moderna IncMRNA
    McKesson CorporationMCK
    Boston Scientific CorpBSX

    Sector: Healthcare

    ELV Analyst Ratings

    Consensus
    Buy
    Analysts
    22
    Strong Buy
    2
    Buy
    12
    Hold
    8
    Sell
    0
    Strong Sell
    0

    ELV Bull Case vs Bear Case

    Bull case

    • ELV beat EPS estimates in 75.0% of its last 8 reported quarters.
    • 63.6% of ELV's analyst ratings are Buy or Strong Buy.

    ELV Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    15.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $7.07

    ELV Dividend

    Forward yield
    1.6%
    Payout ratio
    19.5%
    3Y DPS growth
    10.1%
    5Y DPS growth
    12.5%
    Pay months
    Mar, Jun, Sep, Dec
    ELV dividend history

    Frequently Asked Questions About ELV

    What is ELV's current dividend yield?

    Elevance Health Inc (ELV) has a forward dividend yield of 1.59%.

    Does ELV pay dividends?

    Yes, Elevance Health Inc pays dividends with a forward dividend yield of 1.59%.

    What is ELV's P/E ratio?

    Elevance Health Inc has a price-to-earnings (P/E) ratio of 14.22.

    What is ELV's market cap?

    Elevance Health Inc (ELV) has a market capitalization of $95.41B with a current stock price of $431.47.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In